Clinical Trials Directory

Trials / Completed

CompletedNCT00245401

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
2,070 (planned)
Sponsor
Cordis US Corp. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this PMS registry, named e-CYPHER Stent Registry, is to collect post marketing surveillance data on the CYPHERTM Sirolimus-eluting Coronary Stent following marketing approval, when used in normal clinical practice within the labeled indications.

Conditions

Interventions

TypeNameDescription
DEVICECYPHERTM Sirolimus-Eluting Coronary Stent

Timeline

Start date
2003-08-01
Completion
2004-12-01
First posted
2005-10-28
Last updated
2007-04-04

Source: ClinicalTrials.gov record NCT00245401. Inclusion in this directory is not an endorsement.